Biotech 2012: Innovating in the New Austerity
Biotech 2012: Innovating in the New Austerity - PRINT
Considered required reading by executives in the life sciences industry, this book is an invaluable, one-stop resource for making sense of today¹s changing landscape. Innovating in the New Austerity:
Provides analysis of the life sciences industry with data, graphs, and industry highlights including new product approvals, advances in technology, and details of financing and M&A transactions
Examines how pharmaceutical companies are reinventing themselves to innovate for less in this era of austerity
Tracks the convergence of wireless, mobile, and Internet technologies transforming the economics and delivery of healthcare worldwide
Explores the impact of graying populations on healthcare around the world and how regenerative therapies may slow or reverse the diseases of aging
Gives a detailed view of the rise of emerging markets and how these economies are moving from being centers of low-cost manufacturing to world class innovation
Explains the challenges biofuels developers face in expanding their production to commercial scale
Analyzes the global interplay between business, policy, regulation, and reimbursement Comprehensive, unparalleled coverage of key trends makes Innovating in the New Austerity a critical resource for life sciences professionals.
Download the table of Contents, list of charts, and the entire first chapter for free.
Click here to download now.
Add to cart$549.00